Baxter International's shares plummeted roughly 15% during pre market trading today after the medical device manufacturer issued disappointing guidance for the year ahead. The stock decline reflected investor concerns over the company's weaker-than-expected profit projections, triggering significant selling pressure in early trading sessions. The sharp pre market trading movement underscores how earnings forecasts can dramatically shift market sentiment in the healthcare sector.